JW Therapeutics hauls in $300M IPO just as liso-cel-inspired CAR-T nears the finish line in China
Close to two years after Juno Therapeutics disappeared from Nasdaq, a CAR-T biotech it spawned is settling on a stock exchange on the other …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
